Quantitative determination of geranyl diphosphate levels in cultured human cells

Lipids

Volumn 44, Issue 11, 2009, Pages 1055-1062

  Holstein, Sarah A ^a   Tong, Huaxiang ^a   Kuder, Craig H ^a   Hohl, Raymond J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Farnesyl diphosphate; Fluorescence detection; Geranyl diphosphate; Geranylgeranyl diphosphate; High performance liquid chromatography, isoprenylation; Isoprenoid

Indexed keywords

GERANYLGERANYL PYROPHOSPHATE; ISOPRENOID; MEVINOLIN; PROTEIN FARNESYLTRANSFERASE; ZOLEDRONIC ACID;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CONTROLLED STUDY; ENZYME MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MYELOMA CELL; PROTEIN DETERMINATION;

CELLS, CULTURED; DIPHOSPHATES; DITERPENES; HUMANS; K562 CELLS; LIMIT OF DETECTION; POLYISOPRENYL PHOSPHATES; SESQUITERPENES;

MAMMALIA;

EID: 70449533661     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-009-3355-x     Document Type: Article

References (49)

1. SA Holstein RJ Hohl 2004 Isoprenoids: remarkable diversity of form and function Lipids 39 293 309 10.1007/s11745-004-1233-3 1:CAS:528: DC%2BD2cXmtFWmtbg%3D 15357017 (Pubitemid 38971743)
2. G Popjak WS Agnew 1979 Squalene synthetase Mol Cell Biochem 27 97 116 10.1007/BF00218354 1:CAS:528:DyaL3cXkt1Whsbo%3D 41173
3. FL Zhang PJ Casey 1996 Protein prenylation: molecular mechanisms and functional consequences Annu Rev Biochem 65 241 269 10.1146/annurev.bi.65. 070196.001325 1:CAS:528:DyaK28XktFamtL0%3D 8811180
4. Y Hori A Kikuchi M Isomura M Katayama Y Miura H Fujioka K Kaibuchi Y Takai 1991 Post-translational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins Oncogene 6 515 522 1:CAS:528: DyaK3MXkt1CksLo%3D 1903193
5. DV Banthorpe BV Charlwood MJ Francis 1972 The biosynthesis of monoterpenes Chem Rev 72 115 155 10.1021/cr60276a002 1:CAS:528: DyaE38Xhtlyisrk%3D 4552138
6. CD Poulter JC Argyle EA Mash 1978 Farnesyl pyrophosphate synthetase. Mechanistic studies of the 1-4 coupling reaction with 2-fluorogeranyl pyrophosphate J Biol Chem 253 7227 7233 1:CAS:528:DyaE1cXlvFeju7g%3D 701246
7. KM Swanson RJ Hohl 2006 Anti-cancer therapy: targeting the mevalonate pathway Curr Cancer Drug Targets 6 15 37 10.2174/156800906775471743 1:CAS:528:DC%2BD28XhtFCrt7s%3D 16475974
8. SM Grundy 1988 HMG-CoA reductase inhibitors for treatment of hypercholesterolemia N Engl J Med 319 24 33 1:CAS:528:DyaL1cXkvVGmsrw%3D 3288867
9. RK Keller SJ Fliesler 1999 Mechanism of aminobisphosphonate action: characterization of alendronate inhibition of the isoprenoid pathway Biochem Biophys Res Commun 266 560 563 10.1006/bbrc.1999.1849 1:CAS:528: DyaK1MXnvFersbg%3D 10600541 (Pubitemid 30028706)
10. JD Bergstrom RG Bostedor PJ Masarachia AA Reszka G Rodan 2000 Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase Arch Biochem Biophys 373 231 241 10.1006/abbi.1999.1502 1:CAS:528:DC%2BD3cXosVWl 10620343 (Pubitemid 30046509)
11. JE Dunford K Thompson FP Coxon SP Luckman FM Hahn CD Poulter FH Ebetino MJ Rogers 2001 Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates J Pharmacol Exp Ther 296 235 242 1:CAS:528:DC%2BD3MXoslaluw%3D%3D 11160603
12. AA Reszka GA Rodan 2004 Nitrogen-containing bisphosphonate mechanism of action Mini Rev Med Chem 4 711 719 1:CAS:528:DC%2BD2cXmslajsLY%3D 15379639
13. AJ Wiemer JS Yu KM Lamb RJ Hohl DF Wiemer 2008 Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors Bioorg Med Chem 16 390 399 10.1016/j.bmc.2007.09.029 1:CAS:528: DC%2BD1cXlvFSksg%3D%3D 17905588
14. V Charlton-Menys PN Durrington 2007 Squalene synthase inhibitors: clinical pharmacology and cholesterol-lowering potential Drugs 67 11 16 10.2165/00003495-200767010-00002 1:CAS:528:DC%2BD2sXitFGlt7Y%3D 17209661 (Pubitemid 46105084)
15. AD Basso P Kirschmeier WR Bishop 2006 Lipid posttranslational modifications. Farnesyl transferase inhibitors J Lipid Res 47 15 31 10.1194/jlr.R500012-JLR200 1:CAS:528:DC%2BD28XpvVeltg%3D%3D 16278491 (Pubitemid 43107445)
16. F El Oualid LH Cohen GA van der Marel M Overhand 2006 Inhibitors of protein: geranylgeranyl transferases Curr Med Chem 13 2385 2427 10.2174/092986706777935078 1:CAS:528:DC%2BD28XnslOlurY%3D 16918362 (Pubitemid 44184644)
17. AJ Roelofs M Jauhiainen H Monkkonen MJ Rogers J Monkkonen K Thompson 2009 Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP Br J Haematol 144 245 250 10.1111/j.1365-2141.2008.07435.x 19016713
18. JD Bergstrom MM Kurtz DJ Rew AM Amend JD Karkas RG Bostedor VS Bansal C Dufresne FL VanMiddlesworth OD Hensens, et al. 1993 Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase Proc Natl Acad Sci USA 90 80 84 10.1073/pnas.90.1.80 1:CAS:528:DyaK3sXhtFKmsL4%3D 8419946 (Pubitemid 23010253)
19. H Tong SA Holstein RJ Hohl 2005 Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells Anal Biochem 336 51 59 10.1016/j.ab.2004.09.024 1:CAS:528:DC%2BD2cXhtVCgtLbK 15582558 (Pubitemid 39593499)
20. PA Voziyan JS Haug G Melnykovych 1995 Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesol-induced apoptotic cell death Biochem Biophys Res Commun 212 479 486 10.1006/bbrc.1995.1995 1:CAS:528:DyaK2MXntFamtLo%3D 7626062
21. JS Haug CM Goldner EM Yazlovitskaya PA Voziyan G Melnykovych 1994 Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine Biochim Biophys Acta 1223 133 140 10.1016/0167-4889(94)90082-5 1:CAS:528:DyaK2cXls12qurk%3D 8061045 (Pubitemid 24262862)
22. E Bruenger HC Rilling 1988 Determination of isopentenyl diphosphate and farnesyl diphosphate in tissue samples with a comment on secondary regulation of polyisoprenoid biosynthesis Anal Biochem 173 321 327 10.1016/0003-2697(88) 90196-0 1:CAS:528:DyaL1cXmt1Khsro%3D 3189812 (Pubitemid 18233332)
23. RK Keller 1996 Squalene synthase inhibition alters metabolism of nonsterols in rat liver Biochim Biophys Acta 1303 169 179 8908150
24. Y Saisho A Morimoto T Umeda 1997 Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection Anal Biochem 252 89 95 10.1006/abio.1997.2314 1:CAS:528:DyaK2sXmsVWltLc%3D 9324945 (Pubitemid 27408696)
25. L Henneman AG van Cruchten SW Denis MW Amolins AT Placzek RA Gibbs W Kulik HR Waterham 2008 Detection of nonsterol isoprenoids by HPLC-MS/MS Anal Biochem 383 18 24 10.1016/j.ab.2008.08.023 1:CAS:528:DC%2BD1cXht1SiurfO
26. H Tong AJ Wiemer JD Neighbors RJ Hohl 2008 Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue Anal Biochem 378 138 143 10.1016/j.ab.2008.04.021 1:CAS:528:DC%2BD1cXmvFemsLc%3D 18457649
27. AJ Wiemer H Tong KM Swanson RJ Hohl 2007 Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase Biochem Biophys Res Commun 353 921 925 10.1016/j.bbrc.2006.12.094 1:CAS:528:DC%2BD2sXmtVartA%3D%3D 17208200 (Pubitemid 46080385)
28. S Murthy H Tong RJ Hohl 2005 Regulation of fatty acid synthesis by farnesyl pyrophosphate J Biol Chem 280 41793 41804 10.1074/jbc.M504101200 1:CAS:528:DC%2BD2MXhtlajsrvJ 16221687 (Pubitemid 43023147)
29. D McCaskill R Croteau 1993 Procedures for the isolation and quantification of the intermediates of the mevalonic acid pathway Anal Biochem 215 142 149 10.1006/abio.1993.1566 1:CAS:528:DyaK2cXkvFahug%3D%3D 8297005
30. Vial MV, Rojas C, Portilla G, Chayet L, Perez LM, Cori O, Bunton B (1981) Enhancement of the hydrolysis of geranyl pyrophosphate by bivalent metal ions. A model for enzymic biosynthesis of cyclic monoterpenes. Tetrahedron 37:2351-2357
31. DL Pompliano MD Schaber SD Mosser CA Omer JA Shafer JB Gibbs 1993 Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: interactive binding between substrates and a preferred kinetic pathway Biochemistry 32 8341 8347 10.1021/bi00083a038 1:CAS:528: DyaK3sXltlChsro%3D 8347630
32. HP Koeffler DW Golde 1980 Human myeloid leukemia cell lines: a review Blood 56 344 350 1:STN:280:DyaL3M%2FgtV2hsg%3D%3D 6996765
33. HC Rilling E Bruenger LM Leining JE Buss WW Epstein 1993 Differential prenylation of proteins as a function of mevalonate concentration in CHO cells Arch Biochem Biophys 301 210 215 10.1006/abbi.1993.1135 1:CAS:528: DyaK3sXht1WmtrY%3D 8460935
34. SJ Seybold DR Quilici JA Tillman D Vanderwel DL Wood GJ Blomquist 1995 De novo biosynthesis of the aggregation pheromone components ipsenol and ipsdienol by the pine bark beetles Ips paraconfusus Lanier and Ips pini (Say) (Coleoptera: Scolytidae) Proc Natl Acad Sci USA 92 8393 8397 10.1073/pnas.92.18.8393 1:CAS:528:DyaK2MXnvVymurs%3D 11607576
35. AB Gilg JC Bearfield C Tittiger WH Welch GJ Blomquist 2005 Isolation and functional expression of an animal geranyl diphosphate synthase and its role in bark beetle pheromone biosynthesis Proc Natl Acad Sci USA 102 9760 9765 10.1073/pnas.0503277102 1:CAS:528:DC%2BD2MXmsFartb8%3D 15983375 (Pubitemid 40993642)
36. S Carnesecchi Y Schneider J Ceraline B Duranton F Gosse N Seiler F Raul 2001 Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells J Pharmacol Exp Ther 298 197 200 1:CAS:528:DC%2BD3MXksFChtbs%3D 11408542
37. TP Ong R Heidor A de Conti ML Dagli FS Moreno 2006 Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase Carcinogenesis 27 1194 1203 10.1093/carcin/bgi291 1:CAS:528:DC%2BD28XmsVOrsrw%3D 16332721 (Pubitemid 43994863)
38. GL Case L He H Mo CE Elson 1995 Induction of geranyl pyrophosphate pyrophosphatase activity by cholesterol-suppressive isoprenoids Lipids 30 357 359 10.1007/BF02536045 1:CAS:528:DyaK2MXltFCqur4%3D 7609605
39. V Stresing F Daubine I Benzaid H Monkkonen P Clezardin 2007 Bisphosphonates in cancer therapy Cancer Lett 257 16 35 10.1016/j.canlet.2007. 07.007 1:CAS:528:DC%2BD2sXhtFSnt7vP 17697748 (Pubitemid 47464698)
40. H Monkkonen S Auriola P Lehenkari M Kellinsalmi IE Hassinen J Vepsalainen J Monkkonen 2006 A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates Br J Pharmacol 147 437 445 10.1038/sj.bjp.0706628 16402039 (Pubitemid 43292286)
41. H Monkkonen PD Ottewell J Kuokkanen J Monkkonen S Auriola I Holen 2007 Zoledronic acid-induced IPP/ApppI production in vivo Life Sci 81 1066 1070 10.1016/j.lfs.2007.08.007 17850825 (Pubitemid 47418845)
42. M Jauhiainen H Monkkonen J Raikkonen J Monkkonen S Auriola 2009 Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 877 2967 2975 10.1016/j.jchromb. 2009.07.010 1:CAS:528:DC%2BD1MXhtFams7rP 19665949
43. KL Kavanagh K Guo JE Dunford X Wu S Knapp FH Ebetino MJ Rogers RG Russell U Oppermann 2006 The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs Proc Natl Acad Sci USA 103 7829 7834 10.1073/pnas.0601643103 1:CAS:528:DC%2BD28XlsVGksL0%3D 16684881 (Pubitemid 43752866)
44. JM Rondeau F Bitsch E Bourgier M Geiser R Hemmig M Kroemer S Lehmann P Ramage S Rieffel A Strauss JR Green W Jahnke 2006 Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs ChemMedChem 1 267 273 10.1002/cmdc.200500059 1:CAS:528:DC%2BD28XhvFyjur8%3D 16892359
45. KK Chan AM Oza LL Siu 2003 The statins as anticancer agents Clin Cancer Res 9 10 19 1:CAS:528:DC%2BD3sXnt1OnsQ%3D%3D 12538446
46. H Fleisch 2002 Development of bisphosphonates Breast Cancer Res 4 30 34 10.1186/bcr414 1:CAS:528:DC%2BD38XhsFaisLs%3D 11879557 (Pubitemid 34097554)
47. C Baum P Kirschmeier 2003 Preclinical and clinical evaluation of farnesyltransferase inhibitors Curr Oncol Rep 5 99 107 10.1007/s11912-003-0096-5 12583826
48. SA Holstein CL Wohlford-Lenane RJ Hohl 2002 Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB J Biol Chem 277 10678 10682 10.1074/jbc.M111369200 1:CAS:528:DC%2BD38XisVyksbw%3D 11788600 (Pubitemid 34968195)
49. SA Holstein CL Wohlford-Lenane DF Wiemer RJ Hohl 2003 Isoprenoid pyrophosphate analogues regulate expression of Ras-related proteins Biochemistry 42 4384 4391 10.1021/bi027227m 1:CAS:528:DC%2BD3sXisValu74%3D 12693933 (Pubitemid 36457605)